Position history for Walleye Capital LLC's holdings in ABBOTT LABORATORIES
Walleye Capital LLC holds 406,461 shares of ABT (ABBOTT LABORATORIES), worth $41.7M as of 2026-Q1. The position was increased (+117.0% shares). ABT represents 0.2% of Walleye Capital LLC's portfolio.
Current Value
$41.7M
Current Shares
406,461
Total Value Change
+$11.5M
Total Shares Change
+115,588
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 406,461 |
+117.0% |
| $41.7M |
| 0.2% |
| $113.61 |
56 |
| 2025-Q4 | Decreased | 187,266 | -16.7% | $23.5M | 0.1% | $125.15 | 0 |
| 2025-Q3 | Increased | 224,854 | +7.8% | $30.1M | 0.1% | $131.85 | 37 |
| 2025-Q2 | Decreased | 208,655 | -1.3% | $28.4M | 0.1% | $132.52 | 0 |
| 2025-Q1 | Decreased | 211,293 | -4.8% | $28M | 0.1% | $128.41 | 0 |
| 2024-Q4 | Decreased | 222,038 | -16.4% | $25.1M | 0.1% | $110.14 | 0 |
| 2024-Q3 | Decreased | 265,607 | -8.7% | $30.3M | 0.1% | $109.27 | 0 |
| 2024-Q2 | Increased | 290,873 | +94.6% | $30.2M | 0.1% | $100.45 | 46 |